M&A Research Institute Holdings Inc. (JP:9552)
:9552
Want to see JP:9552 full AI Analyst Report?
Top Page
M&A Research Institute Holdings Inc.
(9552)
Select Model
Select Model
Rating:74Outperform
Price Target:
¥1,172.00
▲(5.87% Upside)
Action:Upgraded
Date:06/04/26
The score is driven primarily by strong financial performance (growth, profitability, low leverage, and solid free cash flow). Technicals add caution due to overbought signals despite strong momentum, and valuation appears reasonable but with a low dividend yield.
Positive Factors
Sustained revenue growth
Revenue growth above 20% indicates durable demand for the firm's services and expanding market penetration. Sustained top-line expansion supports reinvestment in capabilities, funds strategic initiatives, and provides a buffer to absorb cost volatility while underpinning longer-term profitability.
Negative Factors
Declining profit margins
Reported declines in gross and net margins point to rising cost pressure or pricing erosion. If persistent, margin contraction reduces operating leverage and free cash flow, forcing tougher allocation choices and potentially limiting sustainable earnings growth despite revenue gains.
Read all positive and negative factors
Positive Factors
Negative Factors
Sustained revenue growth
Revenue growth above 20% indicates durable demand for the firm's services and expanding market penetration. Sustained top-line expansion supports reinvestment in capabilities, funds strategic initiatives, and provides a buffer to absorb cost volatility while underpinning longer-term profitability.
Read all positive factors
M&A Research Institute Holdings Inc. (9552) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥56.64B
Dividend Yield0.45%
Average Volume (3M)273.35K
Price to Earnings (P/E)17.5
Beta (1Y)1.40
Revenue Growth22.69%
EPS Growth-17.39%
CountryJP
Employees690
SectorFinancial
Sector Strength70
IndustryInvestment - Banking & Investment Services
Share Statistics
EPS (TTM)58.48
Shares Outstanding54,101,334
10 Day Avg. Volume273,450
30 Day Avg. Volume273,353
Financial Highlights & Ratios
PEG Ratio-0.53
Price to Book (P/B)14.63
Price to Sales (P/S)4.50
P/FCF Ratio88.07
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)55.75
Revenue Forecast (FY)¥20.72B
M&A Research Institute Holdings Inc. Business Overview & Revenue Model
Company Description
Quants Research Institute Holdings, Inc. operates within Japan, specializing in both mergers and acquisitions (M&A) advisory and media services. The company provides expert M&A guidance, alongside managing a dedicated M&A research portal and a spe...
How the Company Makes Money
null...
M&A Research Institute Holdings Inc. Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
80
Positive
| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.24B | 16.60B | 16.55B | 8.64B | 3.91B | 1.33B |
| Gross Profit | 11.38B | 10.03B | 12.02B | 6.62B | 3.11B | 1.03B |
| EBITDA | 5.91B | 5.31B | 8.46B | 4.51B | 2.10B | 563.14M |
| Net Income | 3.23B | 2.75B | 5.79B | 2.65B | 1.33B | 368.16M |
Balance Sheet | ||||||
| Total Assets | 16.55B | 8.12B | 12.00B | 8.33B | 4.23B | 1.35B |
| Cash, Cash Equivalents and Short-Term Investments | 7.71B | 4.12B | 10.17B | 7.43B | 3.98B | 1.18B |
| Total Debt | 6.57B | 717.76M | 58.76M | 101.71M | 136.30M | 150.06M |
| Total Liabilities | 9.79B | 3.02B | 2.98B | 2.73B | 1.30B | 575.81M |
| Stockholders Equity | 6.76B | 5.10B | 9.02B | 5.60B | 2.93B | 777.77M |
Cash Flow | ||||||
| Free Cash Flow | -1.09B | 847.97M | 5.32B | 3.90B | 2.06B | 653.47M |
| Operating Cash Flow | 4.38B | 976.60M | 5.48B | 3.96B | 2.08B | 678.97M |
| Investing Cash Flow | -5.69B | -251.20M | -308.34M | -400.20M | -79.29M | -57.29M |
| Financing Cash Flow | -1.06B | -6.68B | -2.43B | -110.48M | 804.89M | -347.00K |
M&A Research Institute Holdings Inc. Technical Analysis
Positive
1107.00
Price Trends
776.26
Positive
829.36
Positive
1030.13
Positive
Market Momentum
100.39
Negative
61.43
Neutral
60.37
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9552, the sentiment is Positive. The current price of 1107 is above the 20-day moving average (MA) of 972.20, above the 50-day MA of 776.26, and above the 200-day MA of 1030.13, indicating a bullish trend. The MACD of 100.39 indicates Negative momentum. The RSI at 61.43 is Neutral, neither overbought nor oversold. The STOCH value of 60.37 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:9552.
M&A Research Institute Holdings Inc. Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥26.33B | 15.32 | ― | 18.63% | 40.56% | 840.38% | |
74 Outperform | ¥56.64B | 17.52 | ― | 0.45% | 22.69% | -17.39% | |
74 Outperform | ¥210.47B | 16.16 | 26.65% | 4.00% | 14.02% | 13.94% | |
69 Neutral | ¥110.11B | 16.48 | ― | 1.54% | 4.46% | 7.20% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
56 Neutral | ¥17.52B | 35.10 | ― | 0.24% | ― | ― | |
43 Neutral | ¥14.24B | -11.53 | ― | ― | 180.01% | 33.62% |
* Financial Sector Average
JP:9552
M&A Research Institute Holdings Inc.
1,064.00
-259.00
-19.58%
JP:2127
Nihon M&A Center
643.50
-39.06
-5.72%
JP:2134
Sun Capital Management Corp.
26.00
-7.00
-21.21%
JP:4310
Dream Incubator Inc.
2,774.00
522.07
23.18%
JP:6080
M&A Capital Partners Co. Ltd.
3,580.00
619.07
20.91%
JP:9257
YCP Holdings (Global) Ltd. Japanese Deposit Receipt Repr 1 Sh
780.00
169.94
27.86%
M&A Research Institute Holdings Inc. Corporate Events
Quants Research Institute Advances Share Buyback Under Board-Approved Program
Jun 1, 2026
Quants Research Institute Holdings Inc. has executed a share repurchase of 1,680,400 common shares on the Tokyo Stock Exchange between May 18 and May 31, 2026, for a total consideration of 1,468,429,200 yen. The buyback, conducted as market purcha...
Quants Research Institute Launches Major Share Buyback to Lift Capital Efficiency
May 15, 2026
Quants Research Institute Holdings Inc., a financial and quantitative research services provider listed on the TSE Prime Market, offers data-driven analysis and capital markets solutions to investors and corporate clients. The company operates wit...
Quants Research Institute Outlines FY2026 Q2 Results and Growth Strategy
May 15, 2026
Quants Research Institute Holdings released materials for its FY2026/9 second-quarter financial results presentation, outlining current earnings performance and projections for the full fiscal year. The release also highlighted its medium- to long...
Quants Research Institute Lifts Forecast After Strong Interim Earnings
May 15, 2026
Quants Research Institute Holdings reported strong interim results for the six months ended March 31, 2026, with revenue rising 34.4% year on year to ¥10.3 billion and operating profit up 26.6% to ¥3.0 billion, while interim profit attri...
Quants Research Institute Launches ¥3.8 Billion Share Buyback to Boost Shareholder Returns
May 15, 2026
Quants Research Institute Holdings Inc. has approved a share buyback program aimed at enhancing shareholder returns and improving capital efficiency, reflecting management’s view that the current valuation underestimates the company’s ...
Quants Research Institute Sets Agenda for FY2026 Q2 Results and Growth Strategy
May 15, 2026
Quants Research Institute Holdings Inc. released materials for its financial results presentation covering the second quarter of fiscal year 2026 ending September, outlining current earnings, full-year forecasts, and its medium- to long-term growt...
Quants Research Institute Posts Strong Interim Growth and Lifts Full-Year Outlook
May 15, 2026
Quants Research Institute Holdings reported consolidated revenue of ¥10.3 billion for the six months ended March 31, 2026, up 34.4% year on year, with operating profit rising 26.6% to ¥3.0 billion and interim profit attributable to owner...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.